Listen: Kidney Disease, Diabetes And Janssen Pharmaceuticals discussed on Dr. Daliah
"Seven zero C D A L so diabetes is in the news. And they say that this new drug that's been out INVOKANA may actually slow kidney disease. It helps blood sugar people diabetes. And now they're saying that it actually made protect the kidneys. This study was done by Janssen pharmaceuticals. The study tested Janssen pharmaceuticals. Doug, inva- Kana and results studied Sunday. At a medical mean in Australia and published by the New England Journal of medicine. Found that thirteen thousand people type two diabetes and chronic kidney disease. Right. We're giving INVOKANA dummy pills. And independ- and the trial found that those on the inva- Khanna had a thirty percent lower risk of either kidney failure need for dialysis. Need for kidney transplant or death by kidney disease? For every one thousand people taking the drug there will be forty seven fewer cases of people with kidney disease. So this INVOKANA study Jansa, which is part of Johnson Johnson happened because Johnson and Johnson sponsored the study. Now, the drug costs about five hundred bucks a month. It's an expensive drug, but it works by helping get rid of extra shiver through the through the through the kidneys. And so on one end, you really can't use it if you have kidney disease, but on the other end if it helps accelerate your your healing, or you're recovering from diabetes and lessening the severity of the diabetes. You're gonna protect your kidneys. So this is a"